Eclipsys warns on second quarter:
This article was originally published in Clinica
Healthcare software company Eclipsys has warned that it expects its second-quarter performance to be below previous guidance. The Boca Raton, Florida-based company expects revenues to be $52-54m, rather than the expected $62-65m. It expects a pro forma loss per share of $0.04-0.06 compared with pro forma EPS of $0.11-0.13. The company attributed the shortfall to delays in contract negotiations.